Real-world use of submaximal doses of long-acting GLP-1 receptor agonist semaglutide in patients with obesity: a prospective observational study.

Scientific reports

Implementation of the IWQOL-Lite-CT in Observational Research: Comparison of Baseline Scores With a Clinical Trial Population and Psychometric Evaluation.

Clinical obesity

Comprehensive Long-Term Changes in Cardiovascular Risk Biomarkers With Tirzepatide: A SURMOUNT-1 Post Hoc Analysis.

Journal of the American College of Cardiology

Kidney and Survival Benefits of Semaglutide in Diabetes With Chronic Kidney Disease: FLOW Trial Cardiovascular Subgroup Analyses.

Journal of the American College of Cardiology

Optimization of nursing strategies for semaglutide treatment in overweight type 2 diabetes based on gene polymorphism.

Frontiers in clinical diabetes and healthcare

Risk factors for drug-related impaired gastric emptying: a pharmacovigilance analysis of the FDA adverse event reporting system.

Frontiers in pharmacology

GLP-1 Receptors Are Enriched in the Lymphatic Endothelium and Their Pharmacological Activation With Semaglutide Improves the Pumping Capacity of Lymphatic Vessels.

Microcirculation (New York, N.Y. : 1994)

Glucagon-like peptide 1 receptor agonist use and risk of arthroplasty for knee osteoarthritis: retrospective database analysis.

Regional anesthesia and pain medicine

Reptides currently has 47 peptides ranked from S-F S tier: Tirzepatide Semaglutide Retatrutide Liraglutide Tesamorelin HGH HCG GHK-Cu A tier: SS-31 PT-141 Sermorelin BPC-157 TB-500 CJC+Ipa blend CJC-1295 Ipamorelin BPC+TB blend Melanotan II KLOW GLOW B tier: Cagrisema

🚨 For those interested in PEPTIDES please read up: My goal is to TRAIN and EDUCATE as many medical professionals about the proper use of peptides over the next 5 years. I’m working behind the scenes on the legal and FDA-related availability but IMO that’s an inevitability. https://t.co/uo0l4QBLg9

India’s GLP-1 market has exploded from ₹121 crore to ₹1,736 crore in four years. After semaglutide’s patent expiry on 20 March, 13 companies launched 26 brands within a week. Prices crashed from nearly ₹16,000 per month to as low as ₹1,290, with Glenmark pricing a weekly

The peptides with the most human clinical data, listed. Not results. Not anecdotes. Strictly human trial evidence. 1.Semaglutide (the “OG” GLP-1) GLP-1 receptor agonist. Quiets food noise, slows gastric emptying, drives significant weight loss. 2.Tirzepatide (the upgrade)

📢 ผลเสียของการปักกาที่ไม่มีใครเตือน‼️ ⛔ระวังสูญเสียมวลกล้ามเนื้อและกระดูกพรุน ​ยากลุ่ม GLP-1 receptor agonists คือยาจำพวก เซมากลูไทด์ (Semaglutide - ชื่อการค้า Ozempic, Wegovy) และยาทิรเซพาไทด์ (Tirzepatide - ชื่อการค้า Mounjaro, Zepbound) จากการวิจัยภายใน 52 อาทิตย์ https://t.co/MoXEVORcgI

Tadalafil users Airlines lost my bag, inside were my a few of my daily stack including; Tadalafil, Semaglutide & Tirzepatide, BPC-157, Thymosin Beta-4, CJC-1295 & Ipamorelin, Epithalon, GHK-Cu, Semax & Selank and DSIP. Luckily I still have most of my others. What do I do?

1/ The word “peptide” has become almost meaningless on social media. Some peptides have decades of human data, known receptors, and FDA approval. Others are supported primarily by animal studies, mechanistic theories, and anecdotes. The most important takeaway from Dr. Abud https://t.co/VlySymIWg7

@nicknorwitz Imagine knee or shoulder surgery along with IV drip of BPC-157 pre, during, and post surgery recovery. 24hrs of peptide therapy. Hospital and fda approved. Maybe hgh and IGF as well.